• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前驱期和早期运动型帕金森病的报告症状:基于患者视角的范围综述

Reported Symptoms in Prodromal and Early Motor Parkinson's Disease: A Scoping Review on the Patient Perspective.

作者信息

Saade Joseph, van Wyk Alice, Stebbins Glenn T, Mestre Tiago A

机构信息

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

Division of Neurology, Department of Medicine, Hull Hospital, CISSSO, Gatineau, Quebec, Canada.

出版信息

Mov Disord Clin Pract. 2025 Jun;12(6):721-733. doi: 10.1002/mdc3.70007. Epub 2025 Mar 3.

DOI:10.1002/mdc3.70007
PMID:40029012
Abstract

BACKGROUND

The lived experience of Parkinson's disease (PD) includes motor and non-motor symptoms. There is a need to capture the earliest patient experiences in a sensitive and reliable manner for the successful development of interventions that may delay clinical progression in PD.

OBJECTIVE

Our aim was to synthesize published literature about patient-reported symptoms in prodromal and early motor stages of PD and develop a conceptual framework of the earliest lived experiences in PD.

METHODS

We conducted a scoping review of the published literature in MEDLINE, EMBASE, SCOPUS, and CINAHL databases and abstracted patient-reported symptoms from included studies reporting on prodromal or early motor stages of PD populations.

RESULTS

We included 59 articles with data from 64 cohorts (prodromal PD: n = 20/64; 31%, early motor PD: n = 44/64, 69%). Overall, the 10 most frequent symptoms (of 85 standardized reported symptoms [SRSs]) were non-motor. SRSs were grouped into symptom domains (behavioral, cognition, dysautonomia, motor, sensory, sleep, and others) and functional domains (activities of daily living, communication, sexual, and social impairment). The Movement Disorder Society sponsored revision of the Unified Parkinson's Disease Rating Scale parts Ib and II (n = 13/64, 20%) and ad hoc questionnaires (n = 12/64, 19%) were the most frequently used measurement tools.

CONCLUSION

At prodromal and early motor stages of PD, individuals report symptoms of a diverse range of motor and non-motor domains and higher-level functional domains. There is a need to capture the full spectrum of this lived experience in a new patient-reported clinical outcome measure for clinical trials in the earliest clinical stages of PD.

摘要

背景

帕金森病(PD)的生活体验包括运动和非运动症状。为了成功开发可能延缓PD临床进展的干预措施,需要以敏感且可靠的方式捕捉患者最早出现的症状体验。

目的

我们的目的是综合已发表的关于PD前驱期和运动早期患者报告症状的文献,并构建PD最早生活体验的概念框架。

方法

我们对MEDLINE、EMBASE、SCOPUS和CINAHL数据库中已发表的文献进行了范围综述,并从纳入的关于PD人群前驱期或运动早期的研究中提取患者报告的症状。

结果

我们纳入了59篇文章,数据来自64个队列(前驱期PD:n = 20/64;31%,运动早期PD:n = 44/64,69%)。总体而言,85种标准化报告症状(SRSs)中最常见的10种症状是非运动性的。SRSs被分为症状领域(行为、认知、自主神经功能障碍、运动、感觉、睡眠等)和功能领域(日常生活活动、沟通、性功能和社会功能障碍)。运动障碍协会赞助修订的统一帕金森病评定量表第一部分b和第二部分(n = 13/64,20%)和特设问卷(n = 12/64,19%)是最常用的测量工具。

结论

在PD的前驱期和运动早期,个体报告了各种运动和非运动领域以及更高层次功能领域的症状。有必要在一种新的患者报告临床结局测量方法中捕捉这种完整的生活体验,用于PD最早临床阶段的临床试验。

相似文献

1
Reported Symptoms in Prodromal and Early Motor Parkinson's Disease: A Scoping Review on the Patient Perspective.前驱期和早期运动型帕金森病的报告症状:基于患者视角的范围综述
Mov Disord Clin Pract. 2025 Jun;12(6):721-733. doi: 10.1002/mdc3.70007. Epub 2025 Mar 3.
2
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的体育锻炼:系统评价与网状Meta分析
Cochrane Database Syst Rev. 2024 Apr 8;4(4):CD013856. doi: 10.1002/14651858.CD013856.pub3.
3
Physical exercise for people with Parkinson's disease: a systematic review and network meta-analysis.帕金森病患者的身体锻炼:系统评价和网络荟萃分析。
Cochrane Database Syst Rev. 2023 Jan 5;1(1):CD013856. doi: 10.1002/14651858.CD013856.pub2.
4
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
5
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.左旋多巴/卡比多巴肠凝胶对晚期帕金森病患者“关”期的长期影响:一项系统评价
Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20.
6
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.对于帕金森病患者,在接受丘脑底核刺激后,抑郁症状会对患者报告的疾病严重程度产生负面影响。
J Parkinsons Dis. 2025 Jun 26:1877718X251354933. doi: 10.1177/1877718X251354933.
7
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.疾病轨迹的生活经历、治疗负担和社会不平等如何影响服务使用者和照顾者参与健康和社会护理:一项基于理论的定性证据综合分析
Health Soc Care Deliv Res. 2025 Jun;13(24):1-120. doi: 10.3310/HGTQ8159.
8
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).静脉注射脂质体GM1治疗帕金森病患者的安全性和耐受性:一项单中心开放标签的I期临床试验(NEON试验)。
PLoS Med. 2025 May 13;22(5):e1004472. doi: 10.1371/journal.pmed.1004472. eCollection 2025 May.
9
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.
10
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.肠道生物标志物、微生物群组成以及炎症性肠病的遗传易感性作为帕金森病表现的预测指标。
J Parkinsons Dis. 2025 May 7:1877718X251328567. doi: 10.1177/1877718X251328567.

本文引用的文献

1
Patient-centered development of clinical outcome assessments in early Parkinson disease: key priorities and advances.早期帕金森病以患者为中心的临床结局评估发展:关键优先事项与进展
NPJ Parkinsons Dis. 2024 May 14;10(1):101. doi: 10.1038/s41531-024-00716-z.
2
Pain in Parkinson disease: mechanistic substrates, main classification systems, and how to make sense out of them.帕金森病疼痛:发病机制基础、主要分类系统,以及如何理解它们。
Pain. 2023 Nov 1;164(11):2425-2434. doi: 10.1097/j.pain.0000000000002968. Epub 2023 Jun 6.
3
Relative Meaningfulness and Impacts of Symptoms in People with Early-Stage Parkinson's Disease.
早期帕金森病患者症状的相对意义和影响。
J Parkinsons Dis. 2023;13(4):619-632. doi: 10.3233/JPD-225068.
4
Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease.前驱期或未识别的帕金森病患者的功能障碍。
JAMA Neurol. 2023 Feb 1;80(2):200-204. doi: 10.1001/jamaneurol.2022.4621.
5
Tracking Emergence of New Motor and Non-Motor Symptoms Using the MDS-UPDRS: A Novel Outcome Measure for Early Parkinson's Disease?使用 MDS-UPDRS 追踪新的运动和非运动症状:早期帕金森病的新疗效指标?
J Parkinsons Dis. 2022;12(4):1345-1351. doi: 10.3233/JPD-223170.
6
Prodromal Parkinson's disease: hype or hope for disease-modification trials?前驱期帕金森病:是疾病修饰试验的炒作还是希望?
Transl Neurodegener. 2022 Feb 21;11(1):11. doi: 10.1186/s40035-022-00286-1.
7
Gender differences in motor and non-motor symptoms in early Parkinson disease.帕金森病早期运动和非运动症状的性别差异。
Medicine (Baltimore). 2022 Jan 21;101(3):e28643. doi: 10.1097/MD.0000000000028643.
8
The neuropsychiatry of Parkinson's disease: advances and challenges.帕金森病的神经精神医学:进展与挑战。
Lancet Neurol. 2022 Jan;21(1):89-102. doi: 10.1016/S1474-4422(21)00330-6.
9
Self-Report versus Clinician Examination in Early Parkinson's Disease.帕金森病早期的自我报告与临床检查。
Mov Disord. 2022 Mar;37(3):585-597. doi: 10.1002/mds.28884. Epub 2021 Dec 13.
10
A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson's Disease: A Qualitative Study.以患者为中心的早期帕金森病症状及其影响的概念模型:一项定性研究。
J Parkinsons Dis. 2022;12(1):137-151. doi: 10.3233/JPD-202457.